PDS Biotechnology Corporation

PDSB · NASDAQ
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Operating Activities
Net Income-$9,009-$9,434-$8,489-$7,952
Dep. & Amort.$5$15$5$5
Deferred Tax$0$0$0$0
Stock-Based Comp.$1,246$0$1,254$1,644
Change in WC$1,386-$1,244-$2,288-$2,239
Other Non-Cash$455$1,562$486$307
Operating Cash Flow-$5,916-$9,101-$9,032-$8,234
Investing Activities
PP&E Inv.$0$0$0$0
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$0$0$0$0
Investing Cash Flow$0$0$0$0
Financing Activities
Debt Repay.-$1,015-$19,703-$3,140-$3,139
Stock Issued$1,257$20,699$7,300$3,168
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$0$0$3,161$145
Financing Cash Flow$241$996$7,321$173
Forex Effect$0$0$0$0
Net Chg. in Cash-$5,675-$8,105-$1,711-$8,062
Supplemental Information
Beg. Cash$31,873$39,979$41,690$49,751
End Cash$26,199$31,873$39,979$41,690
Free Cash Flow-$5,916-$9,101-$9,032-$8,234